1. An endogenous peptide positively selects and augments the activation and survival of peripheral CD4+ T cells.
- Author
-
Lo WL, Felix NJ, Walters JJ, Rohrs H, Gross ML, and Allen PM
- Subjects
- Amino Acid Substitution, Animals, Antigens, CD immunology, Antigens, Differentiation, T-Lymphocyte immunology, CD4-Positive T-Lymphocytes cytology, Cell Line, Cell Proliferation, Lectins, C-Type, Ligands, Mice, Mice, Transgenic, Protein Binding, Thymus Gland cytology, Thymus Gland immunology, CD4-Positive T-Lymphocytes immunology, Histocompatibility Antigens Class II immunology, Lymphocyte Activation, Peptides immunology, Receptors, Antigen, T-Cell immunology
- Abstract
Although CD4(+) and CD8(+) T cells differ in the strength of their positively selecting signal, endogenous positively selecting ligands have been identified only for major histocompatibility complex (MHC) class I-restricted T cell antigen receptors (TCRs). Here we screened for ligands able to positively select MHC class II-restricted TCRs using thymocytes from four I-E(k)-restricted TCR-transgenic mice and a large panel of self peptides. One peptide, gp250, induced positive selection of AND CD4(+) T cells, had no homology with the AND TCR agonist ligand and was recognized with a high degree of specificity. The gp250 peptide acted as a coagonist to initiate the activation and enhance the survival of peripheral AND CD4(+) T cells. Thus, positively selecting ligands are critical in thymocyte development and in the activation and maintenance of peripheral T cells.
- Published
- 2009
- Full Text
- View/download PDF